Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06881069 · ClinicalTrials.gov registry record · NA
Reach Through Equitable Implementation in Utah
A NA study of Tobacco Use and Tobacco Smoking, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 1,560
- Enrollment target
- 1
- Study location
NCT06881069: Recruiting NA study of Tobacco Use and Tobacco Smoking, sponsored by University of Utah.
NCT06881069 is a NA study of Tobacco Use and Tobacco Smoking that is actively recruiting participants, run by University of Utah. The registered enrollment target is 1,560 participants, above the 359-participant average among 76 other Tobacco Use trials with a reported enrollment target (335% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06881069, a NA study of Tobacco Use and Tobacco Smoking, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,560 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pragmatic, multilevel Type III Hybrid Effectiveness-Implementation trial is to increase the reach of existing evidence-based interventions (EBIs) for tobacco cessation and to mitigate the impact of adverse Social Drivers of Health (SDOH) among safety-net healthcare system patients who live in persistent poverty (PP) census tracts. Aim 1: Test the ability of patient-level Conversational Agents (CA) \& Patient Navigation (PN) dissemination strategies to increase the Reach (primary outcome) of evidence-based tobacco cessation treatment delivered via the Utah Tobacco and Nicotine Quit Services (Quit Services) among Community Health Center (CHC) patients who use tobacco and live in persistent poverty census tracts. Secondary analyses will examine the outcome of Reach of services for SDOH among these patients and will evaluate both 1) patient-level CA and PN dissemination strategies and 2) a clinic-level implementation strategy using a pre-post design. Aim 2: Explore contextual factors (e.g., clinic size, patient composition, rurality, patient demographics) related to the Reach, Adoption, Implementation, and potential Maintenance of strategies. Aim 3: Determine the cost-effectiveness of clinic and patient-level strategies based on Quit Services enrollment and service receipt for SDOH. This trial implements a clinic-level implementation strategy, Ask-Advise-Connect (AAC), to address tobacco cessation and needs around social drivers of health for patients in all participating clinics. Eligible patients who are not enrolled in Quit Services four weeks after the clinical encounter, will receive text messages from a chatbot offering information and connections to the Quit Services and patient navigation support from a Community Health Worker.
Primary Outcome
Reach of the Quit Services is the number of eligible patients who officially enroll in the Quit Services over the total number of eligible patients.
Conditions Studied
Interventions
- BEHAVIORAL Clinic Level: AAC - SDOH, AAC - Tobacco
- BEHAVIORAL Non-Bundled
- BEHAVIORAL Bundled
- BEHAVIORAL Dose 1
- BEHAVIORAL Dose 3
Study Locations (1)
Utah
- Huntsman Cancer Institute at the University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,560 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2028-01-30 |
| Phase | NA |
What NCT06881069 shows while recruiting
NCT06881069 is an interventional study that assigns participants to a tested intervention. Its 1,560 participants enrollment target places it among the larger protocols in the corpus, above the 359-participant average among 76 other Tobacco Use trials with a reported enrollment target (335% higher).
The record links to 5 conditions, with Tobacco Use appearing as the primary indexed condition, and to 5 interventions - of which Clinic Level: AAC - SDOH, AAC - Tobacco is the first listed.
NCT06881069 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06881069 about?
NCT06881069 is a clinical study titled "Reach Through Equitable Implementation in Utah". The goal of this pragmatic, multilevel Type III Hybrid Effectiveness-Implementation trial is to increase the reach of existing evidence-based interventions (EBIs) for tobacco cessation and to mitigate the impact of adverse Social Drivers of Health (SDOH) among safety-net healthcare system patients w...
What is the current status of trial NCT06881069?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,560 participants. The study started on 2025-02-13. Estimated completion is 2028-01-30.
What conditions does trial NCT06881069 study?
This clinical trial studies the following conditions: Tobacco Use, Tobacco Smoking, Tobacco Use Cessation, Tobacco Dependence, Tobacco Chewing.
What interventions are being tested in trial NCT06881069?
The interventions under investigation include: Clinic Level: AAC - SDOH, AAC - Tobacco (BEHAVIORAL), Non-Bundled (BEHAVIORAL), Bundled (BEHAVIORAL), Dose 1 (BEHAVIORAL), Dose 3 (BEHAVIORAL).
Who is sponsoring clinical trial NCT06881069?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06881069 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06881069's enrollment target sits among peer trials
1,560 4th of 76 higher than 73 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI